EUCTR2008-001325-34-IT
Active, not recruiting
Not Applicable
PROMISE AMI (PROtection of coronary Microcirculation by Iloprost: Safety and Efficacy evaluation in Acute Myocardial Infarction treated by primary PCI) Pilot Study - Promise AMI
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 sitesJune 20, 2008
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
- Status
- Active, not recruiting
- Last Updated
- 12 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Age \> 18 y
- •2\.Acute myocardial infarction (STEMI) with ST segment elevation in at least two contiguous leads and thoracic pain lasting over 20 minutes and less than 6 hours
- •3\.Informed Consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •1\.Acute myocardial infarction without ST elevation (NSTEMI)
- •2\.Complete left bundle branch block
- •3\.Previous STEMI in the same territory
- •4\.Contraindications to anti\-platelet therapy or IIb/IIIa inhibitors
- •5\.Hypertension (\> 180/100 mmHg)
- •6\.Pregnancy or fertile age
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
EMPIRE-Elafin Myocardial Protection from Ischaemia RepErfusion injury - Effect of elafin on myocardial injuryMyocardial ischaemia reperfusion injury Post-operative inflammation Post-ischaemic inflammatory injuryEUCTR2010-019527-58-GBHS Lothian80
Completed
Not Applicable
Prevention of another myocardial infarction.Heart diseaseCirculatory SystemISRCTN53248571Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Completed
Phase 2
Distal Protection Combined With PTCA in AMI PatientsCoronary Artery DiseaseNCT00264030Cordis Corporation56
Completed
Not Applicable
Secondary Prevention of Acute Coronary Events. Reduction Of Cholesterol to Key European Targets: an open-label comparative investigation of efficacy, tolerance and health in 2,072 patients randomised to rosuvastatin or 'standard' simvastatin therapy following hospital admission for new definition myocardial infarctioISRCTN89508434niversity of Leeds (UK)2,072
Active, not recruiting
Not Applicable
PROtection of coronary Microcirculation by Iloprost:Safety and Efficacy in Percutaneous Coronary Intervention - PROMISE PCIEUCTR2008-001319-39-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI